ANNA KOMOTO: Open Payments
NPI 1437610631 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 15 payments from 7 companies in 2025. Trend: 2023 $562 · 2024 $1,065 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $118 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $16 |
Products named: LEQVIO, JARDIANCE, LifeVest, ELIQUIS, NEXLETOL, Wegovy, REPATHA.
Industry payments across GA — which companies pay providers there.
